SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.

Emerging Microbes & Infections
Chun-Kit YuenKin-Hang Kok


The Coronavirus disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2 virus, is now causing a tremendous global health concern. Since its first appearance in December 2019, the outbreak has already caused over 5.8 million infections worldwide (till 29 May 2020), with more than 0.35 million deaths. Early virus-mediated immune suppression is believed to be one of the unique characteristics of SARS-CoV-2 infection and contributes at least partially to the viral pathogenesis. In this study, we identified the key viral interferon antagonists of SARS-CoV-2 and compared them with two well-characterized SARS-CoV interferon antagonists, PLpro and orf6. Here we demonstrated that the SARS-CoV-2 nsp13, nsp14, nsp15 and orf6, but not the unique orf8, could potently suppress primary interferon production and interferon signalling. Although SARS-CoV PLpro has been well-characterized for its potent interferon-antagonizing, deubiquitinase and protease activities, SARS-CoV-2 PLpro, despite sharing high amino acid sequence similarity with SARS-CoV, loses both interferon-antagonising and deubiquitinase activities. Among the 27 viral proteins, SARS-CoV-2 orf6 demonstrated the strongest suppression on both primary interferon production an...Continue Reading


Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
Aug 19, 2007·Archives of Biochemistry and Biophysics·Holger A LindnerRobert Ménard
Feb 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yu ChenDeyin Guo
Oct 20, 2009·Nature Structural & Molecular Biology·Wataru KamitaniShinji Makino
Feb 26, 2010·Journal of Virology·Mark A ClementzSusan C Baker
Apr 28, 2010·PLoS Pathogens·Mickaël BouvetEtienne Decroly
May 11, 2012·Current Opinion in Virology·Allison L Totura, Ralph S Baric
Dec 24, 2013·Nature Reviews. Immunology·Lionel B Ivashkiv, Laura T Donlin
Feb 22, 2014·Annual Review of Immunology·William M SchneiderCharles M Rice
May 4, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G-U KimS-H Kim

❮ Previous
Next ❯


Oct 2, 2020·Pharmaceuticals·Anastasiia I Petushkova, Andrey A Zamyatnin
Jun 26, 2020·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sandra Pellegrini, Gilles Uzé
Aug 7, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelvin Kai-Wang ToKwok-Yung Yuen
Oct 11, 2020·Cell Death and Differentiation·Toshifumi MatsuyamaTak W Mak
Oct 13, 2020·Research and Practice in Thrombosis and Haemostasis·Mansour GergiRalph C Budd
Nov 6, 2020·Expert Opinion on Investigational Drugs·Maricar MalinisJeffrey Topal
Oct 27, 2020·Frontiers in Immunology·Nima TaefehshokrBryan Heit
Dec 3, 2020·Respiratory Research·Meghana RastogiSunit K Singh
Dec 19, 2020·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Hongjie Xia, Pei-Yong Shi
Dec 19, 2020·Frontiers in Microbiology·Tanveer AhmadSyed Mansoor Ali
Dec 15, 2020·Wellcome Open Research·Stefan BressonDavid Tollervey
Jan 1, 2021·Journal of Structural Biology·Munazza Shahid, Syed Shahzad-Ul-Hussan
Jan 9, 2021·Journal of Biomolecular Structure & Dynamics·M Elizabeth SobhiaHarmanpreet Singh
Dec 29, 2020·Biochemical and Biophysical Research Communications·Koki KatoRichard W Wong
Jan 26, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Prem RajakSumedha Roy
Sep 28, 2020·Cell Reports·Hongjie XiaPei-Yong Shi
Feb 3, 2021·Emerging Microbes & Infections·Serena DelbuePasquale Ferrante
Nov 16, 2020·The Lancet. Respiratory Medicine·Phillip D MonkUNKNOWN Inhaled Interferon Beta COVID-19 Study Group
Nov 24, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bianza Moise BakadiaGuang Yang
Nov 19, 2020·Emerging Microbes & Infections·Joy-Yan LamKin-Hang Kok
Feb 4, 2021·Journal of Inflammation Research·Bushra MdkhanaRabih Halwani
Jan 5, 2021·Frontiers in Molecular Biosciences·Giuseppina MarianoJulien R C Bergeron
Feb 18, 2021·Life Science Alliance·Mengran WangSusan Dina Ghiassian
Oct 29, 2020·Cellular & Molecular Immunology·Yu-Zhi FuYan-Yi Wang
Jan 17, 2021·Trends in Microbiology·Rahul K SuryawanshiDeepak Shukla
Feb 3, 2021·International Journal of Molecular Sciences·Nicholas A Wong, Milton H Saier
Feb 28, 2021·Cellular & Molecular Immunology·Wenjing WangJianwei Wang
Mar 3, 2021·Genetics and Molecular Biology·Michel Satya NaslavskyMayana Zatz
Mar 6, 2021·Emerging Microbes & Infections·Kelvin Kai-Wang ToKwok-Yung Yuen
Feb 21, 2021·Cytokine & Growth Factor Reviews·Jorge Quarleri, M Victoria Delpino
Feb 23, 2021·Virus Evolution·Gal AlmogArt F Y Poon
Mar 2, 2021·Frontiers in Pharmacology·Zhihong ZuoMeichun Deng
Mar 10, 2021·Biochemical and Biophysical Research Communications·Luca Zinzula

❮ Previous
Next ❯

Methods Mentioned

flow cytometry
nuclear translocation

Software Mentioned

Clustal Omega

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.